SCHEMBL3289225

SCHEMBL3289225

CC1=Cc2c(sc3ccccc23)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.41
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
DRD4 P21917 1/20 0.39
DRD5 P21918 1/20 0.39
DRD3 P35462 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.33
IDO1 P14902 2/20 0.33
TDO2 P48775 1/20 0.33
PNMT P11086 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
HSD17B10 Q99714 1/20 0.32
FTO Q9C0B1 1/20 0.32
RAB9A P51151 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16949487 0.84 GPR3 (0.40) GPR3DRD2DRD1DRD4DRD5
SCHEMBL3292309 0.70 GPR3 (0.41) GPR3DRD2DRD1DRD4DRD5
SCHEMBL1824700 0.69 MAPK1 (0.38) ALDH1A1MAPTCYP1A2CYP2D6RAB9A
SCHEMBL21941917 0.68 GPR3 (0.35) GPR3DRD2DRD1DRD4DRD5
SCHEMBL1826346 0.68 GRM6 (0.41) ALDH1A1MAPTNFKB1HSD17B10RAB9A
SCHEMBL1825499 0.67
SCHEMBL13600308 0.67 GPR3 (0.52) GPR3DRD2DRD1DRD4DRD5
SCHEMBL23430324 0.67 GPR3 (0.38) GPR3ALDH1A1MAPTIDO1TDO2
SCHEMBL24056381 0.67 GPR3 (0.38) GPR3ALDH1A1MAPTPNMTRAB9A
SCHEMBL20604090 0.67 GPR3 (0.41) GPR3DRD2DRD1DRD4DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723450-B2 Transition metal compound, ligand system, catalyst system and process for preparing polyolefins BASELL POLYOLEFINE GMBH (DE) 2010-05-25 US disclosed
US-20070260023-A1 Transition Metal Compound, Ligand System, Catalyst System and Process for Preparing Polyolefins BASELL POLYOLEFINE GMBH (DE) 2007-11-08 US disclosed
EP-1761571-A1 TRANSITION METAL COMPOUND, LIGAND SYSTEM., CATALYST SYSTEM AND PROCESS FOR PREPARING POLYOLEFINS Basell Polyolefine GmbH (DE) 2007-03-14 EP disclosed
WO-2005118654-A1 TRANSITION METAL COMPOUND, LIGAND SYSTEM, CATALYST SYSTEM AND PROCESS FOR PREPARING POLYOLEFINS BASELL POLYOLEFINE GMBH (DE) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070260023-A1 Transition Metal Compound, Ligand System, Catalyst System and Process for Preparing Polyolefins ZYX, ZC3HAV1L, ZKSCAN2 GPR3 3790/4885DRD2 1975/4885DRD1 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.